POR and phenylketonuria: Therefore, the approach involving transplantation of Cypor-deficient healthy hepatocytes is feasible for PKU, but unsuitable for treating HoFH, indicating that a one-size-fits-all gene editing strategy is not viable for inherited metabolic liver diseases.